BRKR - ブルカ― （Bruker Corporation） ブルカ―BRKRのチャート
BRKRの企業情報
| symbol | BRKR |
|---|---|
| 会社名 | Bruker Corp （ブルカ―） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Biotechnology: Laboratory Analytical Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 ブルカー(Bruker Corporation)は生命科学、製薬、バイオテクノロジー、臨床と分子診断研究、及び様々な産業と政府用途での材料および化学分析分野における多様な顧客層の急速に変化するニーズに対応する科学機器のグローバルなメーカー。同社の技術プラットフォームは磁気共鳴技術、質量分析技術、ガスクロマトグラフィー技術、X線技術、スパーク発光分光分析法、原子間力顕微鏡法、スタイラス及び光学的測定技術、並びに赤外線とラマン分子分光法技術を含む。同社は化学・生物・放射性物質・核・爆発物（CBRNE）探知用の一連のフィールド分析システムを製造・販売する。平成24年4月、同社はSkyScan N.V.を買収した。 ブルカ―は、米国の生命科学関連の分析装置メ―カ―。最先端科学の研究に取り組む企業や研究機関へMRI（生体用核磁気共鳴装置）、EPR（電子常磁性共鳴装置）、X線回折装置・分析装置、ナノ表面分析システム、質量分析装置、赤外分光計・その周辺機器などを販売し、アフタ―サ―ビスを提供する。 right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www |
| 本社所在地 | 40 Manning Road Billerica MA 01821 USA |
| 代表者氏名 | Frank H. Laukien フランクH.ローキン |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 978-663-3660 |
| 設立年月日 | 33270 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 6200人 |
| url | www.bruker.com |
| nasdaq_url | https://www.nasdaq.com/symbol/brkr |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 313.30000 |
| 終値（lastsale） | 33.24 |
| 時価総額（marketcap） | 5196102727.2 |
| 時価総額 | 時価総額（百万ドル） 4914.725 |
| 売上高 | 売上高（百万ドル） 1841.5 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 4876.625 |
| 当期純利益 | 当期純利益（百万ドル） 160.70000 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Bruker Corporation revenues increased 9% to $875.4M. Net income increased 29% to $58.2M. Revenues reflect Bruker Scientific Instruments segment increase of 11% to $789.4M. Net income benefited from Bruker Scientific Instruments segment income increase of 21% to $82.9M Bruker Energy_Supercon Technologies segment income increase of 56% to $3.9M Eliminations segment income totaling $100K vs. $0K. |
BRKRのテクニカル分析
BRKRのニュース
Global Optogenetics Market Report 2023: Major Players Include Elliot Scientific, Shanghai Laser & Optics Century, GenSight Biologics and Danaher 2023/06/08 01:45:00 Kwhen Finance
Bruker Files Mixed Shelf 2023/06/02 20:21:02 Investing.com
https://www.investing.com/news/assorted/bruker-files-mixed-shelf-432SI-3097407
Bruker goes ex dividend tomorrow 2023/05/30 20:42:04 Seeking Alpha
Bruker (NASDAQ:BRKR) has declared $0.06/share quarterly dividend, 20% increase from prior dividend of $0.05.Payable June 16; for shareholders of record June 1; ex-div May 31.See BRKR…
Global Nano-electromechanical Systems Market is Anticipated to Soar at 21.8 % CAGR and Reach a Worth of US$ 785 Billion | Data by Future Market Insights, Inc. 2023/05/22 02:03:00 Accesswire
NEWARK, DE / ACCESSWIRE / May 21, 2023 / The global nanoelectromechanical systems market revenue was estimated at US$ 108.8 Billion in 2022. Over the next ten years, global nanoelectromechanical system sales are anticipated to soar at 21.8 % CAGR. By 2032, the total market value is expected to reach US$ 785 Billion. Micromachining is projected to remain the most commonly used technology for making MEMS. As per the latest report from Future Market Insights (FMI), the micromachining segment is likely to exhibit a CAGR of 21.6% from 2022 to 2032. Increasing defense spending and rising integration of NEMS in smartphones are projected to expand the nanoelectromechanical systems market. Nanoelectromechanical systems (NEMS) are nanoscale devices that combine electrical and mechanical components. They can be utilized for a wide variety of applications, such as sensing, actuation, and signal processing. These systems typically consist of structures with diameters smaller than 100 nanometers. Get an overview of market drivers and challenges affecting this industry: https://www.futuremarketinsights.com/reports/sample/rep-gb-17151 Nanoelectromechanical systems are employed in a variety of applications such as sensors and actuators.
Bruker: Fundamental, Market Generated Data Corroborate Buy Thesis 2023/05/19 09:15:10 Seeking Alpha
Bruker Corporation continues to demonstrate attractive economic characteristics. Click here to find out why BRKR stock is a Buy.
Increasing Cloud Computing Adoption to Boost Cloud ELN Service Market; FMI Analysts Predict Market Valuation to Surpass US$ 1,203.3 million by 2033 | Report by Future Market Insights, Inc. 2023/05/08 14:00:00 Accesswire
NEWARK, DE / ACCESSWIRE / May 8, 2023 / The global cloud Electronic Lab Notebook (ELN) market size is anticipated to surpass US$ 332.3 million in 2023. It is anticipated to hit US$ 1,203.3 million by 2033. The global market is anticipated to develop at a striking CAGR of 13.7% from 2023 to 2033. Data security, accessibility, and precision are all guaranteed by cloud ELN services. They enable data and workflow access from any location via an internet connection, enhancing cooperation inside the enterprise. Enterprises of all sizes benefit from cloud ELN services as they are affordable and efficient. The rising integration of advanced technologies is flourishing in growth for the market. Data security is utmost crucial for enterprises and cloud ELN services help businesses to steer through these cyber threats. Businesses can add additional resources to be more efficient and help in maximizing growth potential. Pharmaceutical and life science industries are increasing cloud ELN service adoption.
Bruker acquires ZONTAL for digital lab transformation and biopharma data solutions 2023/05/08 11:20:32 Seeking Alpha
Bruker (BRKR) has closed the acquisition of ZONTAL, an innovative platform provider for the digital transformation of the analytical laboratory, and for integrated biopharma technical…
Bruker Corporation 2023 Q1 - Results - Earnings Call Presentation 2023/05/06 16:08:16 Seeking Alpha
The following slide deck was published by Bruker Corporation in conjunction with their 2023 Q1 earnings call.
Bruker Corporation (BRKR) Q1 2023 Earnings Call Transcript 2023/05/06 16:08:10 Seeking Alpha
Bruker Corporation (NASDAQ:NASDAQ:BRKR) Q1 2023 Earnings Conference Call May 4, 2023 8:30 AM ETCompany ParticipantsJustin Ward - Senior Director of IR & Corporate DevelopmentFrank…
Bruker Non-GAAP EPS of $0.64 beats by $0.09, revenue of $685.3M beats by $45.67M 2023/05/04 13:19:58 Seeking Alpha
Bruker press release (BRKR): Q1 Non-GAAP EPS of $0.64 beats by $0.09.Revenue of $685.3M (+15.2% Y/Y) beats by $45.67M.Bruker increases FY 2023 guidance for revenue to…
Canopy Biosciences, Enable Medicine to advance research on spatial biology 2023/04/12 11:26:27 Seeking Alpha
Bruker''s (BRKR) unit Canopy Biosciences is collaborating with Enable Medicine to bring advanced spatial analysis pipelines to ChipCytometry platform. Read more here
The 3 Most Promising Biotech Stocks to Buy Now 2023/03/21 13:00:58 InvestorPlace
This year the National Institutes of Health is set to request its biggest budget yet for 2024, on the heels of its previous biggest budget in 2023. As the COVID-19 pandemic fades from view, labs will switch back to other avenues of research, often funded by the NIH. This higher level of funding, coming on the heels of the COVID-19 pandemic and associated biotech boom, could be big money for the people who make and sell equipment. As the saying goes, in a gold rush, the best job is a shovel salesman. University labs are the biggest beneficiaries of NIH funding. These groups tend to be smaller than corporate labs and have less time to compare every product line when purchasing. Therefore, they tend to purchase from large, trusted companies above all else. I will be discussing three companies that are well-known by researchers, making them some of the most likely beneficiaries of the NIH’s largesse. Ultimately, these three companies have positioned themselves well as some of the most promising biotech stocks to buy in 2023.
Bruker nabs two 1.2 GHz NMR systems orders from the U.K. 2023/03/17 11:57:52 Seeking Alpha
Bruker (BRKR) is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance nuclear magnetic resonance spectrometers for the University of…
Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK 2023/03/17 11:00:00 Wallstreet:Online
Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and the University of Birmingham. Each institution already has a Bruker 1.0 GHz NMR spectrometer and will advance their capabilities further for research into the materials properties for
Proteomics Global Market Report 2023 2023/02/23 16:53:00 GlobeNewswire
Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc. Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc.